SEC Form D private-offering filing

MultiValent Biotherapies, Inc.

A new SEC Form D private-offering notice from Los Altos, CA, a $4,375 filer-stated offering target in Biotech. The source filing is one click away.

MultiValent Biotherapies, Inc. site↗ Verified via SEC Form D

Develops targeted drug conjugate therapies for cancer, including a dual targeting prostate cancer treatment licensed from Coherent Biopharma.

Filed 2026-02-27Filed to raise $4,375First money in 2026-01-05Raised so far $4,375HQ (as filed) Los Altos, CASector Biotech ✓Stage (inferred) Pre-seedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified multivalentbiotherapies.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.